1. Home
  2. UCAR vs CPHI Comparison

UCAR vs CPHI Comparison

Compare UCAR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$1.85

Market Cap

9.2M

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.69

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCAR
CPHI
Founded
2013
N/A
Country
China
China
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
UCAR
CPHI
Price
$1.85
$1.69
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
32.6K
11.7K
Earning Date
10-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,816,075.00
$4,052,266.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
57.22
N/A
52 Week Low
$1.74
$1.20
52 Week High
$9.43
$3.35

Technical Indicators

Market Signals
Indicator
UCAR
CPHI
Relative Strength Index (RSI) 32.67 53.42
Support Level $1.77 $1.45
Resistance Level $1.95 $1.88
Average True Range (ATR) 0.13 0.09
MACD -0.02 0.03
Stochastic Oscillator 7.55 58.14

Price Performance

Historical Comparison
UCAR
CPHI

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: